Found 0 matching trials
To Demonstrate Superiority of Decitabine Over Azacitidine in Subjects With Intermediate- or High-risk MDS. PHASE4 The purpose of this study is to compare the response of patients with Inter...
Show More Location
Birmingham Hematology and Oncology Associates
Learn More & Join Trial
An Extension to Study AZA PH GL 2003 CL 001 Allowing for Continuation of Azacitidine Treatment in Patients With Myelodysplastic Syndromes (MDS) PHASE3 At the conclusion of study AZA PH GL 2003 CL 001 (NCT00071799), eligible pa...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety, Clinical Activity, Pharmacokinetics (PK) and Pharmacodynamics Study of GSK2879552, Alone or With Azacitidine, in Subjects With High Risk Myelodysplastic Syndromes (MDS) PHASE1 This is a Phase I/II, open-label, 2 arm study to evaluate the safety and cl...
Show More Location
GSK Investigational Site
Learn More & Join Trial
AMG 176 With Azacitidine in Subjects With Myelodysplastic Syndrome /Chronic Myelomonocytic Leukemia PHASE1 The main objective is to assess the safety, tolerability, and efficacy of A...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
A Safety and Efficacy Study of Pracinostat and Azacitidine in Patients With High Risk Myelodysplastic Syndromes PHASE2 This is a Phase 2, two-stage study of the safety and efficacy of pracinosta...
Show More Learn More & Join Trial
Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations PHASE2 The goal of this clinical trial is to evaluate the efficacy and safety of v...
Show More Location
Ethical Committee of the First Affliated Hospital of Soochow University
Learn More & Join Trial
MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia PHASE1 An open-label, multicenter, phase 1, dose escalation study of MLN4924 in ad...
Show More Location
Stanford University Medical Center
Learn More & Join Trial
A Biomarker-Directed Phase 2 Trial of Tamibarotene (SY-1425) in Participants With Acute Myeloid Leukemia or Myelodysplastic Syndrome PHASE2 The purpose of this study is to determine the activity of tamibarotene in p...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma PHASE1 The purpose of this study is to compare the amount of drug that gets into t...
Show More Location
California Cancer Care Inc
Learn More & Join Trial
A Study of Cusatuzumab in Combination With Azacitidine Compared With Azacitidine Alone in Patients With Higher-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) and Who Are Not Candidates for Hematopoietic Stem Cell Transplantation (HSCT) PHASE2 The purpose of the study is to compare overall response rate (ORR) between ...
Show More Location
St Vincents Hospital Sydney
Learn More & Join Trial